Thoracic aortic aneurysm and dissection (
TAAD) is a life-threatening
cardiovascular disease with severe extracellular matrix (ECM) remodeling that lacks efficient early stage diagnosis and nonsurgical
therapy. A
disintegrin and
metalloproteinase with
thrombospondin motif 7 (ADAMTS-7) is recognized as a novel locus for human coronary artery
atherosclerosis. Previous work by us and others showed that ADAMTS-7 promoted
atherosclerosis, postinjury
neointima formation, and
vascular calcification. However, whether ADAMTS-7 is involved in
TAAD pathogenesis is unknown. We aimed to explore the alterations in ADAMTS-7 expression in human and mouse
TAAD, and investigate the role of ADAMTS-7 in
TAAD formation. A case-control study of
TAAD patients (N = 86) and healthy participants (N = 88) was performed. The plasma ADAMTS-7 levels were markedly increased in
TAAD patients within 24 h and peaked in 7 days. A
TAAD mouse model was induced with 0.5% β-
aminopropionitrile (
BAPN) in
drinking water. ELISA analysis of mouse plasma, Western blotting, and immunohistochemical staining of aorta showed an increase in ADAMTS-7 in the early stage of
TAAD. Moreover, ADAMTS-7-deficient mice exhibited significantly attenuated
TAAD formation and
TAAD rupture-related mortality in both male and female mice, which was accompanied by reduced artery dilation and inhibited
elastin degradation. ADAMTS-7 deficiency caused repressed inflammatory response and
complement system activation during
TAAD formation. An increase in plasma ADAMTS-7 is a novel
biomarker for human
TAAD. ADAMTS-7 deficiency attenuates
BAPN-induced murine
TAAD. ADAMTS-7 is a potential novel target for
TAAD diagnosis and
therapy. KEY MESSAGES: A case-control study revealed increased plasma ADAMTS-7 is a risk factor for
TAAD. ADAMTS-7 was elevated in plasma and aorta at early stage of mouse
TAAD. ADAMTS-7 knockout attenuated mouse
TAAD formation and mortality in both sexes.